According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

Research suggests GLP-1s like Ozempic may help with more than just weight loss and type 2 diabetes, but experts warn of risks from abuse.

According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung

Early data are promising, but GLP-1 drugs aren't yet recommended as IBD therapy